| 52.97 Data as of May 24 |  +0.24 / +0.46%Today’s Change | 41.68 Today|||52-Week Range 53.45 | +21.85% Year-to-Date |
| Elan Rejects Royalty Offer Again - Analyst Blog May 24 / Zacks.com | Toll Reports Better-than-Expected Earnings: Ahead of the Ticker May 22 / TheStreet.com |
| Want to invest in Samsung? Good luck! May 24 / CNNMoney.com | XenoPort Candidate Disappoints - Analyst Blog May 21 / Zacks.com |
| Impax Launches Generic Zomig - Analyst Blog May 23 / Zacks.com | Elan Provides Strategic Update - Analyst Blog May 21 / Zacks.com |
| Data on UCB's Neupro - Analyst Blog May 22 / Zacks.com | GlaxoSmithKline Stock Hits New 52-Week High (GSK) May 21 / TheStreet.com |
| XenoPort Resumes Horizant Supply - Analyst Blog May 22 / Zacks.com | Dirty Medicine May 15 / Fortune |
| Previous close | 52.73 |
| Today’s open | 52.42 |
| Day’s range | 52.38 - 53.07 |
| Volume | 1,283,412 |
| Average volume (3 months) | 2,721,147 |
| Market cap | $130.5B |
| Dividend yield | 4.43% |
| Earnings growth (last year) | -12.13% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +8.13% |
| Revenue growth (last year) | -4.52% |
| P/E ratio | -- |
| Price/Sales | 2.54 |
| Price/Book | 13.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck & Co Inc | -0.17 | -0.36% |
| SNYSanofi SA | +0.30 | +0.55% |
| NVSNovartis AG | +0.54 | +0.73% |
| BMYBristol-Myers Squibb... | +0.40 | +0.85% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.84 |
| Annual revenue (last year) | $42.1B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 17.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Andrew Philip Witty |
Chief Financial Officer & Executive Director Simon Dingemans |
Corporate headquarters Brentford, Greater London |
.
